T. Rowe Price Associates’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $741K | Buy |
78,581
+15,506
| +25% | +$170K | ﹤0.01% | 2279 |
|
|
2025
Q4 | $784K | Buy |
63,075
+2,618
| +4% | +$34.8K | ﹤0.01% | 2187 |
|
|
2025
Q3 | $867K | Buy |
60,457
+4,066
| +7% | +$55.7K | ﹤0.01% | 2129 |
|
|
2025
Q2 | $692K | Buy |
56,391
+4,745
| +9% | +$68.9K | ﹤0.01% | 2148 |
|
|
2025
Q1 | $1.14M | Buy |
51,646
+4,556
| +10% | +$107K | ﹤0.01% | 1890 |
|
|
2024
Q4 | $1.07M | Buy |
47,090
+4,452
| +10% | +$97.2K | ﹤0.01% | 1938 |
|
|
2024
Q3 | $775K | Buy |
42,638
+614
| +1% | +$14.2K | ﹤0.01% | 2071 |
|
|
2024
Q2 | $1.23M | Buy |
42,024
+6,603
| +19% | +$196K | ﹤0.01% | 1809 |
|
|
2024
Q1 | $1.26M | Buy |
35,421
+2,114
| +6% | +$84.5K | ﹤0.01% | 1804 |
|
|
2023
Q4 | $1.45M | Buy |
33,307
+1,929
| +6% | +$75.9K | ﹤0.01% | 1692 |
|
|
2023
Q3 | $1.2M | Buy |
31,378
+910
| +3% | +$38.3K | ﹤0.01% | 1713 |
|
|
2023
Q2 | $1.25M | Sell |
30,468
-2,908
| -9% | -$140K | ﹤0.01% | 1688 |
|
|
2023
Q1 | $1.92M | Buy |
33,376
+1,172
| +4% | +$66K | ﹤0.01% | 1473 |
|
|
2022
Q4 | $1.81M | Sell |
32,204
-3,381
| -10% | -$172K | ﹤0.01% | 1509 |
|
|
2022
Q3 | $1.51M | Buy |
35,585
+5,373
| +18% | +$275K | ﹤0.01% | 1559 |
|
|
2022
Q2 | $1.63M | Buy |
30,212
+149
| +0.5% | +$8.95K | ﹤0.01% | 1689 |
|
|
2022
Q1 | $1.93M | Buy |
30,063
+1,712
| +6% | +$113K | ﹤0.01% | 1695 |
|
|
2021
Q4 | $1.9M | Sell |
28,351
-1,887
| -6% | -$128K | ﹤0.01% | 1738 |
|
|
2021
Q3 | $2.07M | Buy |
30,238
+1,551
| +5% | +$110K | ﹤0.01% | 1710 |
|
|
2021
Q2 | $1.96M | Sell |
28,687
-140
| -0.5% | -$9.9K | ﹤0.01% | 1741 |
|
|
2021
Q1 | $1.99M | Sell |
28,827
-1,663
| -5% | -$113K | ﹤0.01% | 1724 |
|
|
2020
Q4 | $1.98M | Buy |
30,490
+614
| +2% | +$33K | ﹤0.01% | 1640 |
|
|
2020
Q3 | $1.41M | Sell |
29,876
-4,980
| -14% | -$237K | ﹤0.01% | 1661 |
|
|
2020
Q2 | $1.64M | Buy |
34,856
+4,711
| +16% | +$232K | ﹤0.01% | 1593 |
|
|
2020
Q1 | $1.35M | Buy |
30,145
+1,164
| +4% | +$61.1K | ﹤0.01% | 1609 |
|
|
2019
Q4 | $1.69M | Buy |
28,981
+2,143
| +8% | +$128K | ﹤0.01% | 1669 |
|
|
2019
Q3 | $1.61M | Buy |
26,838
+237
| +0.9% | +$14.1K | ﹤0.01% | 1634 |
|
|
2019
Q2 | $1.49M | Buy |
26,601
+24
| +0.1% | +$1.24K | ﹤0.01% | 1686 |
|
|
2019
Q1 | $1.48M | Buy |
26,577
+130
| +0.5% | +$6.62K | ﹤0.01% | 1693 |
|
|
2018
Q4 | $1.19M | Buy |
26,447
+89
| +0.3% | +$4.88K | ﹤0.01% | 1733 |
|
|
2018
Q3 | $1.74M | Sell |
26,358
-1
| -0% | -$62 | ﹤0.01% | 1667 |
|
|
2018
Q2 | $1.7M | Buy |
26,359
+74
| +0.3% | +$4.58K | ﹤0.01% | 1638 |
|
|
2018
Q1 | $1.46M | Buy |
26,285
+124
| +0.5% | +$6.5K | ﹤0.01% | 1651 |
|
|
2017
Q4 | $1.25M | Buy |
26,161
+1,690
| +7% | +$82.7K | ﹤0.01% | 1711 |
|
|
2017
Q3 | $1.24M | Hold |
24,471
| – | – | ﹤0.01% | 1721 |
|
|
2017
Q2 | $1.33M | Buy |
24,471
+5
| +0% | +$239 | ﹤0.01% | 1675 |
|
|
2017
Q1 | $1.03M | Buy |
24,466
+5,300
| +28% | +$226K | ﹤0.01% | 1784 |
|
|
2016
Q4 | $822K | Buy |
19,166
+6
| +0% | +$244 | ﹤0.01% | 1849 |
|
|
2016
Q3 | $791K | Sell |
19,160
-800
| -4% | -$33.5K | ﹤0.01% | 1835 |
|
|
2016
Q2 | $796K | Sell |
19,960
-6,180
| -24% | -$222K | ﹤0.01% | 1777 |
|
|
2016
Q1 | $880K | Buy |
26,140
+6,000
| +30% | +$187K | ﹤0.01% | 1751 |
|
|
2015
Q4 | $683K | Sell |
20,140
-5,660
| -22% | -$177K | ﹤0.01% | 1822 |
|
|
2015
Q3 | $768K | Sell |
25,800
-5,759
| -18% | -$180K | ﹤0.01% | 1787 |
|
|
2015
Q2 | $869K | Buy |
31,559
+8,318
| +36% | +$222K | ﹤0.01% | 1802 |
|
|
2015
Q1 | $586K | Sell |
23,241
-734
| -3% | -$17.4K | ﹤0.01% | 1919 |
|
|
2014
Q4 | $531K | Hold |
23,975
| – | – | ﹤0.01% | 1944 |
|
|
2014
Q3 | $486K | Hold |
23,975
| – | – | ﹤0.01% | 1946 |
|
|
2014
Q2 | $461K | Buy |
23,975
+4,893
| +26% | +$91.2K | ﹤0.01% | 1989 |
|
|
2014
Q1 | $359K | Sell |
19,082
-5,138
| -21% | -$99.2K | ﹤0.01% | 2072 |
|
|
2013
Q4 | $472K | Sell |
24,220
-118,654
| -83% | -$2.18M | ﹤0.01% | 1934 |
|
|
2013
Q3 | $2.35M | Buy |
142,874
+734
| +0.5% | +$11.8K | ﹤0.01% | 1525 |
|
|
2013
Q2 | $2.13M | Buy |
+142,140
| New | +$2.08M | ﹤0.01% | 1518 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
T. Rowe Price Associates's IART Position: Q1 2026 in Review
T. Rowe Price Associates increased its Integra LifeSciences (IART) stake by 25% in Q1 2026, buying an estimated $170K and bringing the position to 78,581 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.
T. Rowe Price Associates first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.35M in Q3 2013. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- T. Rowe Price Associates held 78,581 shares of Integra LifeSciences worth $741K as of Q1 2026.
- T. Rowe Price Associates bought 15,506 Integra LifeSciences shares in Q1 2026, an estimated $170K.
- Integra LifeSciences made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2279 holding.
- T. Rowe Price Associates first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Integra LifeSciences position peaked at $2.35M in Q3 2013.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.